Buprenorphine/Naloxone Shortage Update: What Patients Need to Know in 2026

The Latest on Buprenorphine/Naloxone Availability in 2026

If you rely on Buprenorphine/Naloxone to manage opioid use disorder, supply disruptions aren't just frustrating — they can feel genuinely dangerous. Missing even a few days of medication can trigger withdrawal symptoms, increase cravings, and put your recovery at risk.

Here's what you need to know about the Buprenorphine/Naloxone supply situation in 2026, what it costs, and how to find it when your pharmacy comes up empty.

Is Buprenorphine/Naloxone Still in Shortage?

As of early 2026, Buprenorphine/Naloxone is not listed on the FDA or ASHP official drug shortage lists. That's the good news. The national supply of generic Buprenorphine/Naloxone sublingual tablets and films is generally stable.

But here's the reality on the ground: many patients still can't find it at their local pharmacy. This disconnect between "no official shortage" and "I can't fill my prescription" is confusing and maddening. The reasons have more to do with pharmacy-level barriers than manufacturing problems.

Why Is It Still Hard to Find?

Even without a formal shortage, several factors make Buprenorphine/Naloxone difficult to locate:

• DEA pharmacy ordering quotas. The DEA limits how much of each controlled substance a pharmacy can order each month. Pharmacies serving many OUD patients can exhaust their quota before month's end.
• Pharmacy stocking policies. Some chain pharmacies carry limited quantities or have restrictive internal policies about dispensing Buprenorphine/Naloxone. This is often rooted in stigma rather than supply constraints.
• Manufacturer-specific disruptions. While the overall supply is stable, individual generic manufacturers occasionally experience production or distribution delays. If your pharmacy relies on a single supplier, a disruption at that company can affect your access.
• Rural access gaps. Patients in rural areas may have only one or two pharmacies within reasonable driving distance, and neither may stock the medication.

For a deeper look at these barriers, read our guide on why Buprenorphine/Naloxone is so hard to find.

What Does Buprenorphine/Naloxone Cost in 2026?

Cost varies widely depending on whether you have insurance, which formulation you use, and which pharmacy you visit:

• Generic sublingual tablets (8mg/2mg): $40-$80 for a 30-day supply with a discount card like GoodRx or SingleCare
• Generic sublingual films: $36-$150 for 30 films with a coupon
• Brand Suboxone Film: $155-$570 for 30 films without insurance
• Brand Zubsolv tablets: $200-$500+ per month without insurance

With insurance, your copay may range from $0 to $75 per month depending on your plan. Medicaid generally covers generic Buprenorphine/Naloxone with little to no copay.

If cost is a barrier, check out our detailed guide on how to save money on Buprenorphine/Naloxone.

Are There New Options in 2026?

The opioid use disorder treatment landscape continues to expand:

• Brixadi — FDA-approved in 2023, this extended-release Buprenorphine injection comes in weekly and monthly formulations. It's an increasingly available option for patients who want to eliminate daily dosing.
• Sublocade — This once-monthly Buprenorphine injection continues to grow in availability and insurance coverage.
• Telehealth prescribing — Federal policies continue to support telehealth prescribing of Buprenorphine, making it easier to get a prescription without an in-person visit. Many telehealth platforms specialize in OUD treatment.
• More generic competition — Multiple manufacturers now produce generic Buprenorphine/Naloxone tablets and films, which has helped keep prices lower than they were a few years ago.

Learn more about alternatives to Buprenorphine/Naloxone if you're having ongoing access issues.

How to Find Buprenorphine/Naloxone in Stock Right Now

Here are the most effective strategies for locating your medication:

1. Use Medfinder. Search for Buprenorphine/Naloxone and see which pharmacies near you have it in stock — in real time.
2. Try independent pharmacies. They tend to have more flexibility in ordering and stocking controlled substances for OUD patients.
3. Call early in the week. Pharmacy shipments often arrive Monday or Tuesday. Stock levels tend to drop by the weekend.
4. Ask your prescriber. Doctors and nurse practitioners who prescribe Buprenorphine/Naloxone often know which local pharmacies reliably carry it.
5. Consider different formulations. If sublingual films are out, sublingual tablets (or vice versa) may be available.

For more detailed strategies, see our guide on how to find Buprenorphine/Naloxone in stock near you.

Final Thoughts

The Buprenorphine/Naloxone supply situation in 2026 is better than many patients fear — there is no national shortage. But real-world access barriers persist, driven by DEA quotas, pharmacy policies, and geographic limitations.

The key is to be proactive: use tools like Medfinder, build relationships with pharmacies that stock your medication, and talk to your prescriber about backup plans if you can't find it.

Your treatment matters, and there are people and tools ready to help you stay on track. Don't hesitate to explore finding a prescriber near you or learning about what to expect from side effects.